PATENT CLAIM ANALYSIS

Application Number: 15876960
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["514", "252100"]

Abstract:
The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

Claim (Index 133):
The method according to  claim 114  for treating a condition selected from Multiple sclerosis, Rheumatoid arthritis, Psoriasis, Type 1 Diabetes, Type II Diabetes, Systemic lupus nephritis, Oncology, Glomerulonephritis, Sj\u00f6grens's syndrome, Transplant rejection, Graft versus host disease, Allergic contact dermatitis, Neointimal hyperplasia/restenosis, Periodontal disease, Leprosy, or Obesity.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 86.0
- Lexical Diversity: 1.54762
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14118170', '15366513', '15026740', '13576798', '14322505']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7696900654338766
- 35 USC 102 Novelty (BERT): 0.545547578958154
- Combined Prediction Score: 0.7472758167863044
- Mean Citation Score: 330.90194
- Max Citation Score: 387.18896
- Similarity Product: 212.43294088663103

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test